In contrast, it has an antiproliferative effect on tumor intestinal CaCo-2 cells and decreases their metabolic viability and mitochondrial membrane potential, which is accompanied by increased apoptosis while significantly reducing the expression of genes for pro-inflammatory interleukins as well as TGF-β. Here, TGFB1 is linked to neoplasm.